Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Changer la santé grâce au soutien alimentaire pour le diabète (CHEFS-DM)

24 septembre 2026 mis à jour par: University of California, San Francisco

La nourriture est un médicament : essai randomisé de soutien alimentaire médicalement adapté pour la santé du diabète

This is a pragmatic randomized controlled trial (RCT) of Changing Health through Food Support for Diabetes (CHEFS-DM). This pragmatic RCT will leverage Project Open Hand's (POH) real-world programs to test the impact of a six month medically tailored food support and nutrition intervention ("CHEFS-DM") on glycemic control and other cardiometabolic outcomes, investigate the paths through which CHEFS-DM may durably improve health, and assess the economic value of the intervention to society.

Aperçu de l'étude

Description détaillée

CHEFS-DM is a six-month intervention providing a diabetes-tailored diet meeting approximately 75% of daily energy requirements and designed based on American Diabetes Association (ADA) guidelines, together with diabetes nutritional education provided by registered dietitians. In this pragmatic RCT, investigators propose to rigorously evaluate the intervention among 440* low-income adults with Type 2 Diabetes Mellitus (T2DM) recruited from networks of safety net clinics in San Francisco and Alameda counties, California.

Participants will be randomized 1:1 to the intervention (n=220*) versus control (n=220*), using a parallel design. The study aims are as follows:

Aim 1: To determine the impact of CHEFS-DM on glycemic control and other cardiometabolic outcomes.

Aim 2: To determine the impact of CHEFS-DM on intermediate outcomes that may mediate any impact of CHEFS-DM on T2DM health.

Participant will be followed for 6 months (control arm) and 12 months (intervention arm) with structured interviews, anthropometric assessments, 24-hour dietary recalls, blood pressure measurements, blood draws, and semi structured interviews. Follow-up will be broken up into two phases. From baseline to six months, researchers will implement the CHEFS-DM intervention and follow both intervention and control arm participants (n=440*). After the end of the six-month follow-up, the intervention arm will transition to receiving standard POH services comprising 33% to 67% of daily energy requirements depending on health status, and will be followed for an additional six months, in order to assess the extent to which any health benefits are sustained at 12 months (n=220*). Hence, the control arm will be followed for six months and participate in two sets of assessments (baseline and at six months), and the intervention arm will be followed for 12 months and participate in three sets of assessments (baseline, six months, and twelve months).

*Update: Due to COVID-era challenges, NIH approved changes to the study in January 2024 including a reduced sample size (at least n=246) and reduced measures and procedures to ease participant burden (see updated SAP Version 2, Section 7, for details).

Type d'étude

Interventionnel

Inscription (Réel)

281

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • California
      • San Francisco, California, États-Unis, 94109
        • Project Open Hand

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Confirmed diagnosis of T2DM confirmed by medical or laboratory records. For T2DM, any of the following criteria will be considered (from the American Diabetes Association):

    • glycated hemoglobin (HbA1c) ≥6.5%, or
    • fasting plasma glucose of ≥126, or
    • a 2-hour plasma glucose level of 200 or higher during a 75 g oral glucose tolerance test, or
    • a random plasma glucose of 200 or higher in patients with symptoms of hyperglycemia
  • Age ≥18 years.

  • Screening positive for food insecurity (at least one positive answer) in the previous 6 months assessed using the 6-item version of the US Household Food Security Survey Module (US Department of Agriculture), or has household income <200% of the federal poverty level.

  • English or Spanish language fluency.

  • Adequate cognitive and hearing capacity to consent and complete study measures.

  • Reside in Alameda County or San Francisco County.

Exclusion Criteria:

  • Type-1 diabetes mellitus
  • Individuals with disorders known to affect the accuracy of the HbA1c measure (e.g., end stage renal disease and individuals with known hemoglobinopathies).
  • Inability to attend the educational workshops.
  • Inability to schedule baseline assessments and/or blood draw after repeated requests.
  • Pregnant individuals, or individuals planning to get pregnant within 6 months, or are lactating, or are postpartum less than 6 months.
  • Current POH clients, past POH clients who stopped services less than 6 months prior, or past or present participants in other POH medically tailored meals studies.
  • Does not have access to food storage, including a refrigerator and freezer to safely keep food.
  • Does not have access to facilities to reheat and prepare meals using Project Open Hand food.
  • Anticipates moving out of study area of Alameda and San Francisco Counties in the next 6 months.
  • Receives more than 1 meal per day from a free food support resource or agency.
  • Allergic to or will not eat eggs, soy, wheat, nuts, seeds or seed oils, or other foods commonly included among ingredients in POH meals.
  • Allergic to dairy products, or unable to tolerate any dairy products including milk, yogurt and cheese.
  • Individual does not eat any or all of POH's meat meal options and will not eat the vegetarian POH meal option.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Aucune intervention: Standard of care

During the active trial period, control participants will receive standard of care as offered by clinical partners to all T2DM patients, meaning that they will receive the same care as if they were not enrolled in the study [no intervention]. This may include referral by their providers to nutritional counseling, T2DM support groups, local diabetes self-management programs, or locally available food support services, entirely independent of the study.

At the end of 6 month follow up (after end of active comparison), the control arm will receive similar services from POH to what the intervention arm received during the intervention, regardless POH eligibility criteria (6 months of DM-tailored food support to meet 67% of their daily requirements, video recording of the 4 CHEFS-DM education classes, and access to a POH dietitian at their request). They will only receive this after their endline assessment period has ended.

Expérimental: Food support and nutrition education

The intervention entails two components: 1) food support that consists of weekly medically tailored meals and healthy groceries that on average covers 75% of daily energy requirements from baseline to six months and 2) diabetes-tailored nutritional education that consists of two individual counseling sessions with a Registered dietitian and four group education sessions.

1. Diabetes-tailored food support. Project Open Hand will provide intervention participants six months of supplemental food support meeting on average 75% of their daily energy requirements. Food support will consist of a mix of meals tailored for T2DM, and T2DM-healthy groceries, consistent with American Diabetes Association (ADA) guidelines for diabetes healthy diets under the responsibility of a registered dietitian.

2. Nutritional counseling and education: The registered dietitian will provide individual nutritional counseling two times (at baseline and month 5-6) during the intervention. In addition, group-based DM nutrition education will be conducted over four 1-hour-long sessions. The nutrition education will be conducted by a POH dietitian, and the curriculum will be consistent with published diabetes self- management education principles, utilizing effective strategies in lower wealth, lower literacy populations.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Change in Hemoglobin A1c From Baseline to Six Months by Study Arm
Délai: Baseline and 6-months follow up

Change HbA1c levels (%) from baseline to six months by study arms.

Baseline and 6-months follow up
Change in Food Insecurity Severity From Baseline to Six Months by Study Arm
Délai: Baseline and 6-months follow-up

The US adult food security survey module from the US Department of Agriculture (USDA) will be used to assess the change in the food security scores from baseline to six months. The score ranges from 0 to 10. Higher score indicates higher severity of food insecurity

Baseline and 6-months follow-up

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Change in the Percentage of Participants With Low and Very Low Food Security
Délai: Baseline and 6-month follow-up

Low and very low food security will be defined as 3 or more items answered affirmatively in the USDA's US adult food security survey module. Change in the percentage of participants with low or very low food security, from baseline to six months by intervention arms, is reported.

Baseline and 6-month follow-up
Change in Percentage of Participants With HbA1c <9% by Study Arm.
Délai: Baseline and 6-month follow-up

Change in percentage of participants with HbA1c < 9%, a threshold indicating poor diabetes control (higher indicates worse diabetes control), from baseline to six months by intervention, arms is reported.

Baseline and 6-month follow-up
Change in Systolic Blood Pressure From Baseline to Six Months
Délai: Baseline and 6-month follow-up

Changes in the average of three repeated measurements of systolic blood pressure (mm Hg) from baseline to six months by study arm.

Baseline and 6-month follow-up
Change in Oral Medication Adherence From Baseline to Six Months by Study Arm
Délai: Baseline and 6-month follow-up

A single-item Rating Visual Analogue Scale is used to evaluate oral diabetes medication adherence. Using the scale, participants self-report the adherence of medication ranging from 0% to 100%. The changes in diabetes medication adherence (percentage) from baseline to six months by study arms are reported.

Baseline and 6-month follow-up
Change in Percentage of Participants With Acute Health Care Utilization From Baseline to Six Month by Study Arm
Délai: Baseline and 6-month

Change in percentage of participants that used emergency health care (Emergency department or urgent care) during the 6 months of the study by study arm is reported.

Baseline and 6-month
Change in Percentage of Participants With a Least One Hospital Admission From Baseline to Six Months by Study Arm
Délai: Baseline to six months

Change in percentage of participants who were hospitalized at least once from baseline to six months of the study by study arms is reported.

Baseline to six months
Change in Percentage of Participants Missing at Least One Outpatient Visit From Baseline to Six Months by Study Arm
Délai: Baseline to six months

Change in percentage of participants that missed at least one outpatient visits from baseline to six months by study arms is reported.

Baseline to six months
Change in Health-related Quality of Life Scores From Baseline to Six Months by Study Arm
Délai: Baseline and 6-month follow-up

The quality of life will be measured using the standardized 12-item short form health survey (SF-12v2). The SF-12v2 provides a summary score for physical and mental health. The transformed T score has a mean=50 and Standard Deviation=10, in which higher values means better health. The change in SF-12 T scores from baseline to six months by study arm will be reported.

Baseline and 6-month follow-up
Change in Body Mass Index (BMI) From Baseline to Six Months by Study Arm
Délai: Baseline and six months

The average of three repeated measurements of weight and height will be obtained at baseline and at six months. The BMI will be calculated (weight (kg)/ (height (m)^2). Changes in in BMI values (kg/ m^2) from baseline to six months by study arm will be reported.

Baseline and six months
Change in Healthy Eating Index Score 2015 (HEI-2015) From Baseline to Six Months by Study Arm.
Délai: Baseline and 6-months follow-up

Dietary information using an automated self- administered 24-hour dietary recall instrument from the National Cancer Institute's (ASA24) will be collected. The HEI-2015 is a measure of diet quality which evaluates how well the food consumed aligns with the Dietary guidelines for American population. The HEI-2015 score ranges from 0-100 in which a higher score indicates better diet quality. The adequacy component of the HEI ranges from 0-60 and the moderation component ranges from 0-40 (both with higher score indicating better diet quality); here the overall score is reported. Changes in the HEI-2015 score from baseline to six months by study arm will be reported.

Baseline and 6-months follow-up
Change in Depressive Symptoms From Baseline to Six Months by Study Arm
Délai: Baseline and six months

The 9-item Patient Health Questionnaire (PHQ-9) will be used to evaluate depressive symptoms. The PHQ-9 score ranges from 0 to 27, with higher scores indicating higher levels of depression. The change in PHQ-9 scores from baseline to six months by study arm will be reported.

Baseline and six months
Change in Diabetes Distress Scale From Baseline to Six Months by Study Arm
Délai: Baseline and 6-month follow-up

The diabetes distress scale (DDS) has 17 items measuring frustration, anger, and discouragement associated with managing complex diabetes health-care directives. The DDS score ranges from 1 to 6, with higher scores indicating higher levels of distress. The change in diabetes distress scores from baseline to six months by study arms will be reported.

Baseline and 6-month follow-up
Change in Diabetes Self-efficacy From Baseline to Six Months by Study Arm
Délai: Baseline and six months

The 8-item Perceived Diabetes Self-Management (PDSM) scale will be used to assess confidence in one's ability to manage numerous self-care behaviors, including diet, and management of glucose. The PDSM scores ranges from 8 to 40, with higher scores indicating more confidence in self-managing their diabetes. The changes in the PDSM scores from baseline to six months by study arm will be reported.

Baseline and six months

Autres mesures de résultats

Mesure des résultats
Description de la mesure
Délai
Durability of HbA1c Values From Six Months to Twelve Months in the Intervention Arm.
Délai: Six and twelve months

To evaluate durability of the HbA1c after the intervention ended, the change in HbA1c levels (%) from six months to twelve months in the intervention group will be reported.

Six and twelve months
Durability in Scores of Food Security From Six to Twelve Months in the Intervention Arm.
Délai: Six and twelve months

To evaluate durability of food security after the intervention ended, the change in food insecurity scores from six months to twelve months in the intervention group will be reported. The US adult food security survey module from the USDA will be used. The score ranges from 0 to 10. Higher score indicates higher severity of food insecurity.

Six and twelve months

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Kartika Palar, PhD, University of California, San Francisco

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Publications générales

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

23 août 2021

Achèvement primaire (Réel)

5 février 2025

Achèvement de l'étude (Réel)

12 juin 2025

Dates d'inscription aux études

Première soumission

25 juin 2021

Première soumission répondant aux critères de contrôle qualité

8 juillet 2021

Première publication (Réel)

13 juillet 2021

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

29 septembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

24 septembre 2026

Dernière vérification

1 septembre 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner